The diagnosis and management of asymptomatic primary hyperparathyroidism (Q36587575)

15 August 2017

1 reference

title

The diagnosis and management of asymptomatic primary hyperparathyroidism (English)

1 reference

15 August 2017

1 reference

2

John P Bilezikian

1 reference

15 August 2017

Shonni J Silverberg

1

1 reference

15 August 2017

1 September 2006

1 reference

Nature Clinical Practice Endocrinology and Metabolism

15 August 2017

1 reference

15 August 2017

2

1 reference

15 August 2017

494-503

1 reference

15 August 2017

9

1 reference

Mild asymptomatic primary hyperparathyroidism is not a risk factor for vertebral fractures.

15 August 2017

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0265

Parathyroid surgery: we still need traditional and selective approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0265

Primary hyperparathyroidism. Incidence, morbidity, and potential economic impact in a community.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0265

7 January 2021

The effects of vitamin D insufficiency in patients with primary hyperparathyroidism

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0265

7 January 2021

Clinical utility of an immunoradiometric assay for parathyroid hormone (1-84) in primary hyperparathyroidism

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0265

7 January 2021

“Incipient” Primary Hyperparathyroidism: A “Forme Fruste” of an Old Disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0265

7 January 2021

Molecular cloning and chromosomal mapping of DNA rearranged with the parathyroid hormone gene in a parathyroid adenoma

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0265

7 January 2021

No evidence for mutations in the calcium-sensing receptor gene in sporadic parathyroid adenomas.

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0265

7 January 2021

Somatic and Germ-Line Mutations of theHRPT2Gene in Sporadic Parathyroid Carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0265

7 January 2021

HRPT2, encoding parafibromin, is mutated in hyperparathyroidism-jaw tumor syndrome

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0265

7 January 2021

HRPT2 mutational analysis of typical sporadic parathyroid adenomas

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0265

7 January 2021

Skeletal disease in primary hyperparathyroidism

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0265

7 January 2021

The histomorphometry of bone in primary hyperparathyroidism: preservation of cancellous bone structure

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0265

7 January 2021

Bone measurements in asymptomatic primary hyperparathyroidism.

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0265

7 January 2021

Parathyroid hormone and periosteal bone expansion

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0265

7 January 2021

Cohort study of risk of fracture before and after surgery for primary hyperparathyroidism.

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0265

7 January 2021

Primary hyperparathyroidism and the risk of fracture: a population-based study

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0265

7 January 2021

A 10-year prospective study of primary hyperparathyroidism with or without parathyroid surgery

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0265

7 January 2021

Nephrolithiasis and bone involvement in primary hyperparathyroidism

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0265

7 January 2021

Cardiac hypertrophy, hypertrophic cardiomyopathy, and hyperparathyroidism--an association

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0265

7 January 2021

Effect of chronic hypercalcemia on the heart. An analysis of 18 necropsy patients

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0265

7 January 2021

Increased risk of death from primary hyperparathyroidism--an update

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0265

7 January 2021

Fractures in patients with primary hyperparathyroidism: nationwide follow-up study of 1201 patients

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0265

7 January 2021

Survival after the diagnosis of hyperparathyroidism: a population-based study

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0265

7 January 2021

Blood pressure in patients with primary hyperparathyroidism before and after parathyroidectomy

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0265

7 January 2021

Primary hyperparathyroidism: incidence of cardiac abnormalities and partial reversibility after successful parathyroidectomy

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0265

7 January 2021

Cardiac abnormalities in patients with primary hyperparathyroidism: implications for follow-up

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0265

7 January 2021

Left ventricular hypertrophy in primary hyperparathyroidism. Effects of successful parathyroidectomy

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0265

7 January 2021

Endothelial vasodilatory function and blood pressure response to local and systemic hypercalcemia

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0265

7 January 2021

Endothelial vasodilatory dysfunction in primary hyperparathyroidism is reversed after parathyroidectomy

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0265

7 January 2021

Impairment of endothelium-independent vasodilation in patients with hypercalcemia.

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0265

7 January 2021

Arterial stiffness in mild primary hyperparathyroidism

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0265

7 January 2021

Neuromuscular disease in primary hyperparathyroidism

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0265

7 January 2021

Neuromuscular involvement in mild, asymptomatic primary hyperparathyroidism

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0265

7 January 2021

Prospective surgical outcome study of relief of symptoms following surgery in patients with primary hyperparathyroidism

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0265

7 January 2021

Randomized trial of parathyroidectomy in mild asymptomatic primary hyperparathyroidism: patient description and effects on the SF-36 health survey.

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0265

7 January 2021

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0265

7 January 2021

A controlled, prospective study of neuropsychological outcomes post parathyroidectomy in primary hyperparathyroid patients.

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0265

7 January 2021

Management of the Zollinger-Ellison syndrome in patients with multiple endocrine neoplasia type 1

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0265

7 January 2021

Hyperparathyroidism and pancreatitis. Chance or a causal association?

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0265

7 January 2021

Age as a criterion for surgery in primary hyperparathyroidism

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0265

7 January 2021

The Anatomic Basis of Parathyroid Surgery

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0265

7 January 2021

Preoperative imaging of abnormal parathyroid glands in patients with hyperparathyroid disease using combination Tc-99m-pertechnetate and Tc-99m-sestamibi radionuclide scans

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0265

7 January 2021

Parathyroid surgery: we only need a minimal surgical approach

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0265

7 January 2021

Six hundred fifty-six consecutive explorations for primary hyperparathyroidism

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0265

7 January 2021

Improved success rate in reoperative parathyroidectomy with intraoperative PTH assay

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0265

7 January 2021

Intraoperative parathyroid hormone testing improves cure rates in patients undergoing minimally invasive parathyroidectomy

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0265

7 January 2021

Long-term evaluation of patients with primary parathyroid hyperplasia managed by total parathyroidectomy and heterotopic autotransplantation

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0265

7 January 2021

Optimal dietary calcium intake in primary hyperparathyroidism

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0265

7 January 2021

Effect of hormone replacement therapy on bone mineral density in postmenopausal women with mild primary hyperparathyroidism. A randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0265

7 January 2021

Raloxifene lowers serum calcium and markers of bone turnover in postmenopausal women with primary hyperparathyroidism

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0265

7 January 2021

Alendronate in the treatment of primary hyperparathyroid-related osteoporosis: a 2-year study

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0265

7 January 2021

Oral alendronate increases bone mineral density in postmenopausal women with primary hyperparathyroidism

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0265

7 January 2021

Alendronate in primary hyperparathyroidism: a double-blind, randomized, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0265

7 January 2021

The calcimimetic cinacalcet normalizes serum calcium in subjects with primary hyperparathyroidism

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0265

7 January 2021

The Story of Hyperparathyroidism at the Massachusetts General Hospital

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0265

7 January 2021

Identifiers

DOI

10.1038/NCPENDMET0265

1 reference

15 August 2017

1 reference

PubMed ID

16957763